How should I assess a patient for retroperitoneal hemorrhage?

Assessment of Retroperitoneal Hemorrhage

For suspected retroperitoneal bleeding, obtain CT angiography (CTA) of the abdomen and pelvis as the initial imaging study in hemodynamically stable patients, or proceed directly to aortography with transcatheter arterial embolization (TAE) in hemodynamically unstable patients with high clinical suspicion. 1

Clinical Recognition

Retroperitoneal bleeding presents with nonspecific symptoms that make clinical diagnosis challenging 1:

• Abdominal pain (67.5% of cases) - diffuse or lower quadrant
• Back pain (21.3%)
• Flank pain with palpable mass
• Hip or leg pain (22-24%)
• Abdominal distension

Critical pitfall: Up to 10% of patients are misdiagnosed on initial encounter because the retroperitoneum is not accessible to physical examination and bleeding can be concealed until hypovolemic shock develops 2. The location posterior to the peritoneum allows large volumes of blood loss before hemodynamic instability becomes apparent 1.

Risk Factors to Identify

• Age >70 years 3
• Anticoagulation therapy (66% of cases): warfarin (42%), heparin (30%), LMWH (11%) 2
• Dual antiplatelet therapy - particularly high risk 3
• Combined anticoagulant-antiplatelet regimen (26% mortality vs 9% with anticoagulant alone) 4
• Recent groin catheterization procedures
• Pelvic or spine fractures in trauma
• Known aortic aneurysm
• Malignancy (second most common site of bleeding in cancer patients) 1

Important: 15-30% of patients are on neither anticoagulants nor antiplatelets 2, so absence of these medications does not exclude the diagnosis.

Imaging Algorithm Based on Hemodynamic Status

Hemodynamically Stable Patients

CT Angiography (CTA) is the appropriate initial study 1:

• Superior sensitivity for detecting active bleeding (detects rates as low as 0.3 mL/min vs 0.5-1.0 mL/min for conventional angiography) 1
• Identifies active contrast extravasation in 78.9-84.2% of cases 1
• Localizes hematoma location and identifies etiology (groin access, pelvic fracture, mass)
• Provides preoperative planning information for vascular anatomy
• Sensitivity 59.5% for active bleeding with positive predictive value 62.9-71% compared to angiographic findings 1

Alternative: Non-contrast CT is appropriate when 1:

• Renal insufficiency present
• Concern about contrast load if angiography may follow
• Need to expeditiously confirm/exclude bleeding
• High attenuation = acute bleeding; mixed attenuation = rebleeding; low attenuation = subacute/chronic 1

Hemodynamically Unstable Patients

Proceed directly to aortography with simultaneous TAE capability 1:

• Reserved for patients with high clinical suspicion and hemodynamic instability
• Allows simultaneous diagnosis and treatment
• Appropriate for known active arterial bleeding or contained vascular injury amenable to intervention
• 100% diagnostic success with cessation of bleeding achieved in all embolization cases 1

Critical timing issue: Delays in diagnosis and treatment are common and associated with high morbidity/mortality 5. The current approach is characterized as "too little, too late" - immediate CTA allows rapid triage without delay 5.

Point-of-Care Ultrasound (POCUS)

Modified POCUS protocols should include retroperitoneal space examination in shocked patients 3:

• Standard adult shock protocols (RUSH) do not routinely include retroperitoneal space
• Can detect retroperitoneal bleeding earlier in unexplained hemorrhagic shock
• 99% sensitive and 98% specific for detecting abdominal aortic aneurysm 1
• Limitations: Cannot reliably detect smaller volumes, determine if bleeding is active, or identify etiology; limited by patient positioning and acoustic windows 1

Modalities That Are NOT Appropriate for Initial Assessment

• Plain radiography: Highly nonspecific, low sensitivity, cannot detect moderate volumes 1
• MRI/MRA: Examination time too long, delays diagnosis and treatment 1
• Ultrasound alone: Insufficient for definitive diagnosis, though useful for AAA screening 1
• RBC scan: Not discussed as appropriate initial imaging 1

Laboratory Findings

• Hemoglobin drop is common but not predictive of mortality (9.07 g/dL in non-survivors vs 9.60 g/dL in survivors, p=0.435) 4
• Serial hemoglobin monitoring essential but do not wait for profound anemia before imaging

Mortality Considerations

• Overall mortality: 5.6% at 7 days, 10.1% at 30 days, 19.1% at 6 months 2
• All non-survivors were on anticoagulants 4
• Time from symptom onset to CT scan does not differ between survivors and non-survivors (1.3 vs 1.5 days, p=0.778) 4, emphasizing need for high clinical suspicion rather than waiting for symptom progression

Management Implications of Imaging Findings

Active contrast extravasation on arterial phase (63% of cases) 6:

• Urgent embolization indicated (successful in 13/17 patients)
• Surgery for actively bleeding hematomas with complications
• Two patients died before intervention could be performed 6

No contrast extravasation or low-flow bleeding (37% of cases) 6:

• Conservative management with clinical, laboratory, and imaging follow-up successful in all cases
• Fluid resuscitation, blood transfusion, close monitoring

The recognition of CT signs of active bleeding is the crucial feature influencing timing of therapeutic treatment 6.